Belatacept conversion in an HIV-positive kidney transplant recipient following anti-thymocyte globulin induction

Samantha A. Kuten, Samir J. Patel, Ashvin Baru, A. Osama Gaber, Rustin D. Crutchley, Venkataraman Ramanathan, Richard J. Knight

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Herein, we describe a case of early belatacept conversion in a human immunodeficiency virus (HIV)-positive kidney transplant recipient in an effort to improve suboptimal graft function and avoid drug interactions following anti-thymocyte globulin (ATG) administration. We observed improvement in renal function without HIV disease progression or opportunistic infections. Donor-specific antibodies appeared shortly after conversion but cleared without intervention. This case highlights belatacept as a means to improve renal function and avoid significant drug interactions even following ATG induction.

Original languageEnglish (US)
Article numbere12748
JournalTransplant Infectious Disease
Volume19
Issue number5
DOIs
StatePublished - Oct 1 2017

Keywords

  • belatacept
  • HIV
  • human immunodeficiency virus
  • kidney transplantation

ASJC Scopus subject areas

  • Transplantation
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Belatacept conversion in an HIV-positive kidney transplant recipient following anti-thymocyte globulin induction'. Together they form a unique fingerprint.

Cite this